Hilton Santa Fe Historic Plaza Hotel Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


This meeting is part of the Global Health Series

Download Flyer

Twitter hashtag for this meeting: #KShfv

Hemorrhagic Fever Viruses (S3)

Scientific Organizers: William E. Dowling and Thomas W. Geisbert


December 4—8, 2016

Hilton Santa Fe Historic Plaza Hotel, Santa Fe, New Mexico, USA


Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Attendees registered for this conference may attend sessions of the concurrent conference on Cellular Stress Responses also taking place in Santa Fe at no additional charge.

DEADLINES:
Global Health Travel Award Deadline: Jul 19, 2016 [details]
Scholarship Deadline: Aug 4, 2016 [details]
Discounted Abstract Deadline: Aug 4, 2016 [details]
Abstract Deadline: Sep 12, 2016 [details]
Discounted Registration Deadline: Oct 4, 2016 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2017-S3 "Hemorrhagic Fever Viruses" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On August 4, 2016 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After August 4, 2016 until October 27, 2016 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
August 4, 2016 n/a
Discounted NON-STUDENT Registration
More details
Before and On October 4, 2016 795.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After October 4, 2016 945.00 USD
Discounted STUDENT Registration
More details
Before and On October 4, 2016 570.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After October 4, 2016 720.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: August 4, 2016


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is September 12, 2016)

Global Health Travel Award Deadline: July 19, 2016


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: August 4, 2016


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: September 12, 2016


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is August 4, 2016)

Discounted Registration Deadline: October 4, 2016


Registration Fee: 795.00 USD* (includes 150.00 USD discount)
Student Registration Fee: 570.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 945.00 USD*
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, December 4 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, December 8 with a closing plenary session from 17:00 to 20:00, followed by a social hour and entertainment. We recommend return travel on Friday, December 9 in order to fully experience the meeting.

SUNDAY, DECEMBER 4

16:00—20:00
Arrival and Registration

Promenade
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Promenade

MONDAY, DECEMBER 5

07:30—08:30
Breakfast

Pecos/Canyon
08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* William E. Dowling, NIAID, National Institutes of Health, USA

* Thomas W. Geisbert, University of Texas Medical Branch, USA

Erica Ollmann Saphire, The Scripps Research Institute, USA
The Molecular Tool-Kit of Hemorrhagic Fever Viruses

09:30—12:15
Innate Immune Evasion I
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Erica Ollmann Saphire, The Scripps Research Institute, USA

Christopher F. Basler, Georgia State University, USA
Ebola Virus VP35 and VP24 are Innate Immune Suppressors and Virulence Determinants

Coffee Break

Elke Mühlberger, Boston University, USA
Silence Is Golden – Distinct Host Responses in Human Macrophages Infected with High or Low Pathogenic Ebolaviruses

Juan Carlos de la Torre, The Scripps Research Institute, USA
Novel Strategies to Developing Therapeutics and Vaccines to Combat Hemorrhagic Fever Arenaviruses

Ana Fernandez-Sesma, Mount Sinai School of Medicine, USA
Modulation of Innate Immunity by Dengue Virus

12:15—14:30
On Own for Lunch

12:15—13:00
Poster Setup

Mesa C
13:00—22:00
Poster Viewing

Mesa C
14:30—16:30
Workshop 1: Innate Immune Evasion II

Mesa A-B
* Christopher F. Basler, Georgia State University, USA

Gaya Amarasinghe, Washington University School of Medicine, USA
Role of Ebola Viral VP24 Protein in Immune Evasion

Hinh Ly, University of Minnesota, Twin Cities, USA
Molecular Mechanisms of Inhibition of Antigen-Presenting Cells by Human Hemorrhagic Fever-Causing Arenaviruses

Colm Atkins, University of Texas Medical Branch, USA
Rift Valley Fever Virus Infection in Human Neuronal Cells

Daniel Stephen Chertow, National Institutes of Health, USA
Role of Ebola Virus Proteins in Bystander Lymphocyte Apoptosis

Lilia Melnik, Tulane University, USA
The Ebola Virus Delta-Peptide Has Viroporin-Like Activity

Jessica R. Spengler, Centers for Disease Control and Prevention, USA
Crimean-Congo Hemorrhagic Fever Virus Strain-Dependent Disease in Humanized Mice

Emily Speranza, Boston University, USA
Delineating Survival from Fatal Outcome in Ebola Virus Disease in Humans

16:30—17:00
Coffee Available

Promenade
17:00—19:00
Host Genetics
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Cesar Muñoz Fontela, Heinrich Pette Institute, Germany
Dissecting Human Immunity to Ebola Virus

Jan E. Carette, Stanford University, USA
Host Factors Involved in Pathogenesis of HFV

Beatriz de la Caridad Sierra Vázquez, Pedro Kouri Institute for Tropical Medicine, PAHO/WHO Collaborating Center, Cuba
Short Talk: Lipid/Cholesterol Metabolism Involved in Viral Replication and Immune Response Provide African-Ancestry Protection Against Dengue Hemorrhagic

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Pecos/Canyon
19:30—22:00
Poster Session 1

Mesa C

TUESDAY, DECEMBER 6

07:30—08:30
Breakfast

Pecos/Canyon
08:30—11:45
Endothelial Dysfunction and Coagulopathy I
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Nigel Mackman, University of North Carolina at Chapel Hill, USA
Coagulation Cascade Activation during Viral Infection

Lisa E. Hensley, NIAID, National Institutes of Health, USA
Late-Stage Filovirus Disease in NHPs

Coffee Break

Anita K. McElroy, Emory University, USA
Endothelial Dysfunction and Coagulopathy during Ebola Virus Disease in Humans

Stefan Kunz, Lausanne University Hospital, Switzerland
Molecular Mechanisms underlying Lassa Virus Invasion of Vascular Endothelial Cells

Dennis A. Bente, University of Texas Medical Branch, USA
Crimean-Congo Hemorrhagic Fever Virus in of the Transmission and Pathogenesis: Current Considerations

11:45—14:30
On Own for Lunch

11:45—13:00
Poster Setup

Mesa C
13:00—22:00
Poster Viewing

Mesa C
14:30—15:30
Workshop 2A: Endothelial Dysfunction and Coagulopathy II

Mesa A-B
* Lisa E. Hensley, NIAID, National Institutes of Health, USA

Roberto Aiolfi, The Scripps Research Institute, USA
Defective Platelet Thromboxane A2 Signaling and Serotonin Release in the Pathogenesis of Bleeding during Viral Infection

Anne-Marie Connolly-Andersen, Umeå University, Sweden
Pulmonary Endothelial Glycocalyx Degradation in Hantavirus Infection

Ashley St. John, Duke-National University of Singapore, Singapore
Dengue Virus-Elicited Tryptase Breaks Tight Junctions to Induce Endothelial Permeability and Shock

Brian Martin Sullivan, The Scripps Research Institute, USA
Linking Platelet Dysfunction to Cytotoxic T Cell Responses during Lethal Viral Hemorrhagic Fever Infection

15:30—16:30
Workshop 2B: Clinical and Immunologic Findings during Lassa Infection

Mesa A-B
* Colleen S. Kraft, Emory University, USA

Aneesh K. Mehta, Emory University, USA
Novel Insights into the Clinical Care of Lassa Disease

Anita K. McElroy, Emory University, USA
The Human Innate and Adaptive Immune Response to Lassa Virus Infection: A Case Study

Lisa Oestereich, Heinrich Pette Institute, Germany
Human Immune Responses to Lassa Infection in Nigeria

16:30—17:00
Coffee Available

Promenade
17:00—19:00
Diagnostics
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Jonathan S. Towner, Centers for Disease Control and Prevention, USA
Filovirus Replication in Naturally and Experimentally Infected Bats

Stephan Günther, Bernhard-Nocht-Institut für Tropenmedizin, Germany
Diagnosis of Ebola Virus Disease during the Outbreak in West Africa

John H. Connor, Boston University School of Medicine, USA
Short Talk: Real-Time Visualization of Individual Hemorrhagic Fever Virions in Solution

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Pecos/Canyon
19:30—22:00
Poster Session 2

Mesa C

WEDNESDAY, DECEMBER 7

07:30—08:30
Breakfast

Pecos/Canyon
08:30—11:30
Vaccines I
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Connie S. Schmaljohn, US Army Medical Research Institute of Infectious Disease, USA

Michael Egan, Profectus Biosciences, USA
Filovirus rVSV Vaccines

Sheri Dubey, Merck & Co., Inc., USA
Clinical Development of a Recombinant Ebola Vaccine in the Midst of an Unprecedented Outbreak

Coffee Break

Heinz Feldmann, Rocky Mountain Laboratories, USA
Lassa rVSV Vaccines

Andrea Marzi, NIAID, National Institutes of Health, USA
Short Talk: Efficacy of VSV-EBOV Post-Exposure Treatment in Rhesus Macaques Infected with EBOV-Makona

Farshad Guirakhoo, GeoVax, Inc., USA
Short Talk: MVA-VLP Platform for Development of a Single Dose Tetravalent Vaccine against Hemorrhagic Fever Viruses

Igor Lukashevich, University of Louisville, USA
Short Talk: Reassortant ML29 Vaccine Platform to Control Lassa Fever in West Africa

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Mesa C
13:00—22:00
Poster Viewing

Mesa C
16:30—17:00
Coffee Available

Promenade
17:00—19:00
Vaccines II
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Heinz Feldmann, Rocky Mountain Laboratories, USA

Anna P. Durbin, Johns Hopkins Bloomberg School of Public Health, USA
The Live Attenuated Dengue Vaccines TV003 and TV005 Completely Protect Against DENV-2 Infection in a Controlled Dengue Human Challenge Model

Shinji Makino, University of Texas Medical Branch, USA
Development of a Single-Cycle Replicable Rift Valley Fever Virus Vaccine

Connie S. Schmaljohn, US Army Medical Research Institute of Infectious Disease, USA
Clinical Assessment of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome (HFRS)

Courtney Brooke Woolsey, University of Texas Medical Branch, USA
Short Talk: A Recombinant Vesicular Stomatitis Virus-Based Vaccine Mediates Post-Exposure Protection against Marburg Virus Angola in Rhesus Macaques

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Pecos/Canyon
19:30—22:00
Poster Session 3

Mesa C

THURSDAY, DECEMBER 8

07:30—08:30
Breakfast

Pecos/Canyon
08:30—11:45
Therapeutics I
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Andrea Marzi, NIAID, National Institutes of Health, USA

Larry Zeitlin, Mapp Biopharmaceutical, Inc., USA
Junin and Filovirus mAb Therapeutics

Thomas W. Geisbert, University of Texas Medical Branch, USA
Filovirus siRNA Therapeutics

Coffee Break

Luis M. Branco, Zalgen Labs, LLC, USA
Lassa Virus Human Monoclonal Antibody Therapeutics

Eric Bergeron, Centers for Disease Control and Prevention, USA
Short Talk: Antiviral Activity and Mechanism of Action of Site-1 Protease (S1P) Inhibitor on Crimean-Congo Hemorrhagic Fever Virus

Zachary Bornholdt, Mapp Biopharmaceutical, USA
Short Talk: The Structure-Based Design of a Pan-ebolavirus Immunotherapeutic Cocktail

Anna Z. Wec, Albert Einstein College of Medicine, USA
Short Talk: Bispecific Antibodies Targeting the Intracellular Virus-Receptor Interaction Provide Broad in vivo Protection Against Ebolaviruses

Bronwyn M. Gunn, Massachusetts General Hospital, USA
Short Talk: Antibody Fc-Effector Functionality Predicts Monoclonal Antibody-Mediated Post-Exposure Protection against Ebola Virus challenge

11:45—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Promenade
17:00—19:15
Therapeutics II
Registered attendees can view abstracts starting on 11/04/2016

Mesa A-B
* Gary Kobinger, University of Manitoba, Canada

Brian Gowen, Utah State University, USA
Prospects for Treatment of Severe Arenavirus and Bunyavirus Infections

M. Javad Aman, Integrated Biotherapeutics, Inc., USA
Short Talk: Cross-Protection Against Ebolaviruses with Vaccine Elicited Broadly Neutralizing Monoclonal Antibody Cocktails: Evidence for Cooperative Neutralization

Travis K. Warren, US Army Medical Research Institute of Infectious Diseases, USA
In vivo Efficacy of BCX4430 Against Ebola Virus

John Misasi, National Institutes of Health, USA
Protective Monotherapy Against Ebola Infection: Structure and Molecular Basis of Potent Neutralization

Ami Patel, Wistar Institute, USA
Short Talk: DNA-Delivery of Monoclonal Antibodies (DMAbs) as an Alternative, in vivo mAb Delivery Platform against Ebola Virus Infection

20:00—21:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Promenade/Mesa Ballroom
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Mesa Ballroom

FRIDAY, DECEMBER 9

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

Bill & Melinda Gates Foundation

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI126804-01

Funding for this conference was made possible [in part] by 1 R13 AI 126804 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Mapp Biopharmaceutical, Inc.


Merck Vaccine Division


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676